Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Iguratimod Tablets
DRUG
2 trials
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
, Wangjing Hospital, China Academy of Chinese Medical Sciences
Conditions
Primary Sjögren's Syndrome
Rheumatoid Arthritis
Phase 4
The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Recruiting
NCT04981145
Second Affiliated Hospital, School of Medicine, Zhejiang University
Primary Sjögren's Syndrome
Start: 2022-01-14
End: 2025-07-31
Target: 78
Updated: 2024-10-16
Unknown Phase
Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis
Not yet recruiting
NCT07115641
Wangjing Hospital, China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
Start: 2025-08-11
End: 2026-08-31
Target: 240
Updated: 2025-08-11
Related Papers
Efficacy and safety of iguratimod in patients with primary Sjögren's syndrome: a multicentre randomised controlled trial.
2025-12-21